| Serial Number | 90236132 |
| Word Mark | LASANTH |
| Filing Date | Monday, October 5, 2020 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Friday, December 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 6, 2021 |
| Goods and Services | Business consulting services in the field of regulatory compliance; business development services; business strategy development services; business consulting and management in the field of clinical trials, namely, regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; business management consulting, strategic planning and business advisory services provided to medical, medical technology, pharmaceutical, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, in the fields of biologics and pharmaceuticals; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for new drugs with governmental regulatory bodies; business consulting services in the field of biologics and pharmaceuticals |
| Goods and Services | Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics and pharmaceuticals |
| Goods and Services | Product research and development for others in the fields of biologics and pharmaceuticals; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics and pharmaceuticals; scientific consulting and research services relating to the field of pharmaceuticals and life sciences, namely, biology, and medicine; consulting services in the fields of biotechnology and pharmaceuticals, namely, design, development, technical verification and technical validation of manufacturing and filling processes, drug formulations, testing protocols and analytical methods; scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 19, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | Saturday, September 30, 2023 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 19, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, September 30, 2023 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 19, 2020 |
| Primary Code | 045 |
| First Use Anywhere Date | Saturday, September 30, 2023 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
| Party Name | Canopy Biopharma LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Whitehouse Station, NJ 08889 |
| Party Name | Canopy Biopharma LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Whitehouse Station, NJ 08889 |
| Event Date | Event Description |
| Thursday, October 8, 2020 | NEW APPLICATION ENTERED |
| Thursday, November 19, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 2, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, March 2, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 17, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 6, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 6, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 1, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, September 27, 2021 | SOU TEAS EXTENSION RECEIVED |
| Monday, September 27, 2021 | SOU EXTENSION 1 FILED |
| Monday, September 27, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 29, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 19, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 19, 2022 | SOU EXTENSION 2 FILED |
| Thursday, May 19, 2022 | SOU EXTENSION 2 GRANTED |
| Saturday, May 21, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 19, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 19, 2022 | SOU EXTENSION 3 FILED |
| Wednesday, October 19, 2022 | SOU EXTENSION 3 GRANTED |
| Friday, October 21, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, April 23, 2023 | SOU TEAS EXTENSION RECEIVED |
| Sunday, April 23, 2023 | SOU EXTENSION 4 FILED |
| Sunday, April 23, 2023 | SOU EXTENSION 4 GRANTED |
| Tuesday, April 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 26, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 26, 2023 | SOU EXTENSION 5 FILED |
| Tuesday, October 3, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 4, 2023 | SOU EXTENSION 5 GRANTED |
| Thursday, October 5, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 26, 2024 | USE AMENDMENT FILED |
| Friday, April 26, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 30, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, May 29, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 29, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, July 17, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 17, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, July 17, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 17, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, August 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 5, 2024 | ASSIGNED TO LIE |
| Friday, December 6, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, December 6, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |